is bpc-157 on fda 503a bulks list staff recommends against adding any of these 7 peptides to the List: • (free base/acetate) • KPV (free base/acetate) • TB-500 (free base/acetate) • MOTS-c (free base/acetate) Industry Update: Interim 503A and
Industry Update: Interim 503A and 503B Bulks Lists New Revisions The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this FDA's July 2026 Peptide Compounding Meeting: What PCAC Could Change for BPC 157, TB 500, Semax, and More PeptideKnow The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York
Pay in 4 interest-free payments of $5.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17

